Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart C Gordon

Showing results (51-60 of 214) with videos related to

Pageof 22
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2022
Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USAHumberto C Gonzalez, Yueren Zhou, Faisal M Nimri, et al.
Clinical Epidemiology|July 27, 2017
Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health recordsMei Lu, Wadih Chacra, David Rabin, et al.
Journal of Clinical Gastroenterology|August 21, 2020
Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver DiseasesRobert J Wong, Nandita Kachru, Diane J Martinez, et al.
The American Journal of Gastroenterology|January 26, 2005
Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirinStephen J Rulyak, Sue C Eng, Keyur Patel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Risk for renal cell carcinoma in chronic hepatitis C infectionStuart C Gordon, Dilip Moonka, Kimberly A Brown, et al.
Hepatology International|July 28, 2023
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemicHumberto C Gonzalez, Faisal M Nimri, Mei Lu, et al.
Advances in Therapy|April 10, 2024
Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and CirrhosisMei Lu, Loralee B Rupp, Christina Melkonian, et al.
Advances in Therapy|January 3, 2024
Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and CirrhosisMei Lu, Loralee B Rupp, Christina Melkonian, et al.
Journal of Hepatology|July 30, 2015
Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantationR Todd Stravitz, Adrian Reuben, Meir Mizrahi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohortEmily Henkle, Mei Lu, Lora B Rupp, et al.
Pageof 22

Showing results (51-60 of 214) with videos related to

Sort By:
Pageof 22
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2022
Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USAHumberto C Gonzalez, Yueren Zhou, Faisal M Nimri, et al.
Clinical Epidemiology|July 27, 2017
Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health recordsMei Lu, Wadih Chacra, David Rabin, et al.
Journal of Clinical Gastroenterology|August 21, 2020
Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver DiseasesRobert J Wong, Nandita Kachru, Diane J Martinez, et al.
The American Journal of Gastroenterology|January 26, 2005
Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirinStephen J Rulyak, Sue C Eng, Keyur Patel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Risk for renal cell carcinoma in chronic hepatitis C infectionStuart C Gordon, Dilip Moonka, Kimberly A Brown, et al.
Hepatology International|July 28, 2023
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemicHumberto C Gonzalez, Faisal M Nimri, Mei Lu, et al.
Advances in Therapy|April 10, 2024
Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and CirrhosisMei Lu, Loralee B Rupp, Christina Melkonian, et al.
Advances in Therapy|January 3, 2024
Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and CirrhosisMei Lu, Loralee B Rupp, Christina Melkonian, et al.
Journal of Hepatology|July 30, 2015
Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantationR Todd Stravitz, Adrian Reuben, Meir Mizrahi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Hepatitis A and B immunity and vaccination in chronic hepatitis B and C patients in a large United States cohortEmily Henkle, Mei Lu, Lora B Rupp, et al.
Pageof 22